Top Markets
Coin of the day
Zoetis Inc. Zoetis Inc.

Zoetis Inc.

ZTS
Rangering i aksjer #830
Zoetis Inc. stands as a global leader in animal health, focusing on the... Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses. Among its pharmaceutical offerings are various therapeutic agents. This includes vaccines, vital for preventing respiratory, gastrointestinal, and reproductive diseases by stimulating a targeted immune response; anti-infectives that combat or inhibit the proliferation of bacterial, fungal, or protozoal pathogens; and parasiticides aimed at eradicating both internal and external pests such as fleas, ticks, and various worms. Additional pharmaceuticals address areas such as pain management and sedation, anti-emesis, reproductive health, and oncology. The portfolio also features dermatological solutions for allergic skin conditions and atopic dermatitis, alongside medicated feed additives specifically designed for livestock. Beyond therapeutics, Zoetis offers an extensive array of diagnostic solutions. These include portable analysis systems for blood and urine, point-of-care testing devices, specialized instruments and reagents, rapid immunoassay kits, comprehensive reference laboratory services, and blood glucose monitoring equipment. Further extending its reach, the company provides supplementary offerings such as nutritional products, agribusiness support services, biodevices, genetic testing, and innovations in precision animal health. Zoetis distributes its diverse product portfolio to a broad customer base, including veterinary professionals, livestock producers, and retail channels. This distribution occurs directly via its sales representatives and technical specialists, as well as through partnerships with third-party veterinary distributors. Established in 1952, the company maintains its corporate headquarters in Parsippany, New Jersey.
Aksjekurs
$71.40
Markedsverdi
$29.93B
Endring (1 dag)
-0.13%
Endring (1 år)
-51.06%
Land
US
Handel Zoetis Inc. (ZTS)

Kategori

Inntekter for Zoetis Inc. (ZTS)
Inntekter i Jun 2026 TTM: $3.27B
Ifølge Zoetis Inc. sine nyeste økonomiske rapporter er selskapets nåværende resultat $3.27B. I 2024 hadde selskapet et resultat på $3.13B, en økning sammenlignet med resultatet i 2023, som var $2.94B. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Zoetis Inc. fra 2009 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
2026 (TTM) $3.27B -2.62%
2025 $3.36B 7.25%
2024 $3.13B 6.71%
2023 $2.94B 10.54%
2022 $2.66B 6.75%
2021 $2.49B 24.65%
2020 $2.00B 10.83%
2019 $1.80B 6.57%
2018 $1.69B 10.82%
2017 $1.53B 24.19%
2016 $1.23B 125.32%
2015 $545.00M -33.54%
2014 $820.00M 18.84%
2013 $690.00M -2.82%
2012 $710.00M 80.20%
2011 $394.00M 121.35%
2010 $178.00M -220.27%
2009 $-148.00M 0.00%
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
$33.59B 926.72%
US
$25.20B 670.05%
US
$8.70B 165.86%
US
$21.39B 553.68%
CH
$5.95B 81.78%
US